Resource Center

Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
Mountain range with trees and river
Sustainability

Quotient Sciences 2023 ESG Report

10 December 2024 Download

61 - 70 of 214 results

On-Demand Webinars, Modified Release, Commercial Manufacturing, Formulation Development
Non-Clinical vs Clinical: Risks & Considerations When Developing Modified Release Dosage Forms
1 September 2022
Watch Now
Scientific Posters, Translational Pharmaceutics, Clinical Pharmacology, Formulation Development
Assessment of the Contribution of CYP2D6 to the Elimination of Idalopirdine as well as the Absolute Bioavailability Following Multiple Oral Dosing
26 August 2022
Download Now
Articles & Publications, Clinical Pharmacology
CC-99677, A Novel, Oral, Selective Covalent MK2 Inhibitor, Sustainably Reduces Pro-inflammatory Cytokine Production
23 August 2022
Download Now
Articles & Publications, Clinical Pharmacology
CC-99677: A Novel, Oral, Selective Covalent MK2 Inhibitor, Sustainably Reduces Pro-inflammatory Cytokine Production
23 August 2022
Download Now
Articles & Publications, Human ADME
ADME of opicapone in human healthy volunteers
16 June 2022
Download Now
On-Demand Webinars, Translational Pharmaceutics
Getting it Right Early: The Importance of Biopharmaceutics in Early Drug Development
1 June 2022
Watch Now
Scientific Posters, Translational Pharmaceutics, Clinical Trial Manufacturing, First-in-Human
Why Archiving is a Crucial Part of Any Clinical Trial
17 May 2022
Download Now
Articles & Publications, Translational Pharmaceutics, Clinical Pharmacology, First-in-Human
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
3 May 2022
Download Now
Scientific Posters, First-in-Human, Translational Pharmaceutics, Clinical Trial Manufacturing, Formulation Development
A First-in-Human (FIH) Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses, and Alternative Formulations of R941552 (R552): A selective Receptor Interacting Protein 1 (RIP1) Kinase Inhibitor
24 March 2022
Download Now
Articles & Publications, Drug Product Optimization
A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors
15 March 2022
Download Now
Get in touch
Humanity can't afford to wait, so neither can we.
Let's talk